Patent ID: 9726683
Date: 2017-08-08
CPC Classifications: G01N,G16H,G16Z

Claim:
1. A method for determining a prediction of risk and/or an indication of extent of coronary stenosis in a human subject, said method comprising the steps of: determining a level of at least one cholesteryl ester selected from the group consisting of: cholesteryl palmitate (CE 16:0), cholesteryl palmitoleate (CE 16:1), cholesteryl stearate (CE 18:0), cholesteryl oleate (CE 18:1), cholesteryl linoleate (CE 18:2), cholesteryl linolenate (CE 18:3), cholesteryl arachidonate (CE 20:4), cholesteryl eicosapentenoate (CE 20:5), cholesteryl docosapentaenoate (CE 22:5), cholesteryl docosahexanoate (CE 22:6), and combinations thereof in a blood sample from said subject; and correlating said level of CE 16:0, CE 16:1, CE 18:0, CE 18:1, CE 18:2, CE 18:3, CE 20:4, CE 20:5, CE 22:5, CE 22:6, or combinations thereof, with a control, thereby providing a prediction of risk and/or indication of extent of coronary stenosis in said subject.